Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD

Inflamm Bowel Dis. 2008 Jan;14(1):125-8; discussion 132-3. doi: 10.1002/ibd.20292.

Authors

Shane M Devlin¹, Marla C Dubinsky

Affiliation

¹ Inflammatory Bowel Disease Center, The University of Calgary, Calgary, Alberta, Canada.

PMID: 17932968
DOI: 10.1002/ibd.20292

No abstract available

MeSH terms

Biomarkers
Genetic Markers
Humans
Inflammatory Bowel Diseases / blood
Inflammatory Bowel Diseases / diagnosis*
Inflammatory Bowel Diseases / genetics
Inflammatory Bowel Diseases / immunology
Prognosis

Substances

Biomarkers
Genetic Markers